نتائج البحث - M Hoyle
- يعرض 1 - 4 نتائج من 4
-
1
-
2
-
3
-
4
The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (mon... حسب M Hoyle, L Crathorne, J Peters, T Jones-Hughes, C Cooper, M Napier, P Tappenden, C Hyde
الحاوية / القاعدة Health Technology Assessment (2013-04-01)احصل على النص الكامل
مقال
